Lohocla 201

Drug Profile

Lohocla 201

Alternative Names: Kindolor®; Lohocla-201

Latest Information Update: 27 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Lohocla Research
  • Class Analgesics; Small molecules
  • Mechanism of Action Nav1.7-voltage-gated-sodium-channel-modulators; Nav1.8 voltage-gated sodium channel modulators; NMDA receptor modulators; Opioid delta receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anxiety disorders; Pain

Most Recent Events

  • 27 Oct 2016 Lohocla Research has patent protection for Lohalca 201 in USA, France, Germany, Switzerland and United Kingsom (Lohocla Research website, October 2016)
  • 27 Oct 2016 Lohocla Research has patents pending for Lohocla 201 in USA and Europe (Lohocla Research website, October 2016)
  • 27 Oct 2016 Preclinical trials in Anxiety disorders in USA (PO) before October 2016
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top